Bios Fund I, Director: Actuate Therapeutics ACTU Buy · Filed 24/08/14

Trade details

Type: Insider buy
Amount: $3,000,000
Shares · price: 375,000 sh · $8.00 a share
Held after: 1,259,427 sh
Stock: Actuate Therapeutics ACTU
Person: Bios Fund IDirector
Trade date: 24/08/14
Filed: 24/08/14
Days to filing: 0 days

First buy since 2023

Insiders buying this week: 23 insiders
Holding change: +42.4%

Actuate Therapeutics trades, last 26 weeks

What else happened in Actuate Therapeutics around then

Filed or reported within 30 days of the trade day · 24/07/15~24/09/13

Bios Fund I's recent trades

Bios Fund IDirector
BuyActuate Therapeutics
Buy
Actuate Therapeutics
ACTU
$500K
71,428 sh
$500K
Filed 25/06/30
Traded 25/06/27
Bios Fund I10% Owner
SellLantern Pharma
Sell
Lantern Pharma
LTRN
$43.9K
14,218 sh
$43.9K
Filed 25/06/13
Traded 25/06/13
Bios Fund I10% Owner
SellLantern Pharma
Sell
Lantern Pharma
LTRN
$38.1K
12,319 sh
$38.1K
Filed 25/06/13
Traded 25/06/13
Bios Fund I10% Owner
SellLantern Pharma
Sell
Lantern Pharma
LTRN
$22.3K
7,206 sh
$22.3K
Filed 25/06/13
Traded 25/06/13
Bios Fund I10% Owner
SellLantern Pharma
Sell
Lantern Pharma
LTRN
$13.5K
4,354 sh
$13.5K
Filed 25/06/13
Traded 25/06/13

Bios Fund I, Director — bought $3M of Actuate Therapeutics ACTU · 375,000 sh @ $8.00 | Whalegun